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Abstract
Background: Clostridium difficile is the leading cause of infectious diarrhea in humans and responsible for large
outbreaks of enteritis in neonatal pigs in both North America and Europe. Disease caused by C. difficile typically occurs
during antibiotic therapy and its emergence over the past 40 years is linked with the widespread use of
broad-spectrum antibiotics in both human and veterinary medicine.
Results: We sequenced the genome of Clostridium difficile 5.3 using the Illumina Nextera XT and MiSeq technologies.
Assembly of the sequence data reconstructed a 4,009,318 bp genome in 27 scaffolds with an N50 of 786 kbp. The
genome has extensive similarity to other sequenced C. difficile genomes, but also has several genes that are
potentially related to virulence and pathogenicity that are not present in the reference C. difficile strain.
Conclusion: Genome sequencing of human and animal isolates is needed to understand the molecular events
driving the emergence of C. difficile as a gastrointestinal pathogen of humans and food animals and to better define
its zoonotic potential.
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Background
Clostridium difficile is a Gram-positive, spore-forming
bacterium that over the last 40 years has emerged from
obscurity to become a leading gastrointestinal pathogen
in hospital environments [1]. The clinical features of dis-
ease range from non-haemorrhagic watery diarrhea to
fatal episodes of pseudomembranous colitis and toxic
megacolon. C. difficile disease is also community-acquired
with incidence rates increasing [2]. In the past decade
C. difficile has caused widespread outbreaks of neona-
tal diarrhea in piglets raising concerns that it may have
a food-borne etiology. One porcine strain of C. difficile
is frequently isolated from human cases of C. difficile
disease in human in Europe, underscoring its zoonotic
potential [3].
Non-toxigenic strains of Clostridium difficile have been
isolated from patients with diarrhoeal disease [4]. Recent
studies showing that nontoxigenic strains are capable of
blocking colonisation and prevent disease caused by tox-
igenic strains indicates that much remains to be learned
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about virulence factors that play important roles in colo-
nization of the gastrointestinal tract [5]. Here we report
the sequence of nontoxigenicC. difficile strain 5.3 isolated
from a patient with diarrhoea. The clinical presentation
of this patient was of suspected Clostridium difficile infec-
tion. This was confirmed at the pathology laboratory with
the isolation of only non-toxigenic C. difficile.
Methods
Isolation and DNA preparation
Clostridium difficile 5.3 originated from a faecal sample
submitted from a female patient with the clinical symp-
tomology of C. difficile infection. From the faecal sample
100 µl of sample was added to cooked meat medium
(TM0102 Oxoid Australia) and incubated anaerobically
using the anoxomat system (MART Microbiology B.B.,
The Netherlands) at 37C for 24 hours. From here 200 µl
of the culture was transferred aseptically into a centrifuge
tube and centrifuged at 10,000 rpm for 5 mins. The super-
natant was discarded and the pellet resuspended in 1ml of
absolute ethanol and incubated at room temperature with
periodic inversion for two hours.
A pellet was recovered by centrifuging at 10,000 rpm
for 5 mins, the ethanol was discarded and the pellet
resuspended in 100 µl of brain heart infusion broth and
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spread plated onto Clostridium difficile selective agar
(CC-BHIA + Taurocholate, PP2362 Oxoid Australia) and
incubated anaerobically at 37 C for 24 hours. All plates
were examined for colonies that morphologically repre-
sented C. difficile, from each plate colonies were selected
and subcultured onto CC-BHIA +Taurocholate until pure
cultures were achieved.
DNAwas extracted from pure cultures by taking a single
colony into 2 ml of brain heart infusion agar and incubat-
ing anaerobically at 37 C for upto 48 hours. The bacterial
suspension was then vortexed and the DNA extracted
using the DNeasy Blood and Tissue Kit (Qiagen, 69581)
using the manufacturers instructions for the extraction of
gram positive bacteria and the use of lysozyme.
Genome sequencing
DNA was quantified using qubit flourimetry and 0.5 ng
gDNA was used as input to the Illumina Nextera XT
library preparation protocol. Tagmentation of Genomic
DNA, and PCR amplification of tagged DNA were per-
formed as per manufacturer’s instructions. However the
“PCR Clean-Up” and “Library Normalization” steps were
omitted and size selection was instead performed by
running balanced and pooled samples in a one percent
agarose gel and excising the 600 bp to 1200 bp region of
interest. The DNA was then purified from the agarose
using Promega’s Wizard SV Gel and PCR Clean-Up Sys-
tem. Finally, an Agilent 2100 Bioanalyzer, with a High
Sensitivity DNA Kit, was used to quantitate the pooled
DNA library before loading onto the MiSeq with 23 other
multiplexed samples. Paired-end 300 nt reads were gener-
ated using MiSeq V3 chemistry.
Assembly and annotation
The genome was assembled using a version of the A5
pipeline [6] called A5-miseq [7] that has been revised to
process reads up to 500 nt long. Briefly, A5-miseq con-
sists of five stages: (1) read quality filtering and error
correction, (2) contig assembly, (3) permissive draft scaf-
folding, (4) misassembly detection, and (5) conservative
scaffolding. The revised A5 pipeline uses a new version
of idba_ud that uses read pairing information, and that
has been modified to accept reads up to 500 nt long and
to construct de Bruijn graphs with k-mers up to 500 nt.
These modifications provide substantial improvements in
assembly contiguity.
The genome was annotated with the RAST annotation
system using FigFAM release 70 [8].
Quality assurance
A5-miseq includes a quality checking step that detects
putative misassemblies by identifying clusters of read
pairs that map to disjoint locations in the assembled
genome. This method did not detect any putative misas-
semblies.
Initial findings
Sequencing generated 925,170 read pairs for a total of
555,102,000 nt that were assembled to reconstruct the
4,009,318 bp genome of C. difficile 5.3 in 27 scaffolds, with
a scaffold N50 of 786 kbp and an N90 of 135 kbp. The
raw (unfiltered) coverage is 138x, and after read filtering
the assembly has a median depth of coverage of 60. The
annotation of this assembly identified 3647 predictedCDS
and 125 predicted RNA genes. 13 genes were identified as
possibly missing from the assembly by the RAST system.
The overall functional profile of the genome is shown in
Figure 1. We conducted a phylogenetic analysis of C. dif-
ficile 5.3 using the PhyloSift software [9] to identify the
most closely related organism with an available reference
genome, using a phylogenetic placement [10] on a tree
constructed from a set of 37 universally conserved genes.
Figure 1 Subsystems in C. difficile 5.3. 47% of the predicted CDS have been assigned to a subsystem in RAST. The functional category with the
largest number of assigned CDS is carbohydrate metabolism, and C. difficile 5.3 has several genes in this functional category that are not present in
the finished genome of C. difficile 630.
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Figure 2 Genome alignment of C. difficileBI1, C. difficile 2007855, C. difficile 630, and C. difficile 5.3. A comparison of the four genomes as
visualized by the Mauve software is shown. The four genomes are free from large-scale rearrangement, and exhibit high levels of sequence identity
throughout their genomes, with a number of differentially conserved regions. Regions conserved among all genomes are shown in the color
mauve, regions shared among subsets of the genomes are in different colors, regions unique to any particular genome are white.
The resulting analysis assigned a posterior probability of
100% for C. difficile 5.3 diverging on the same lineage
as Clostridium difficile 6503. Because Clostridium diffi-
cile 6503 has a draft-quality genome we used the closely
related genome of Clostridium difficile 630 as a reference
for further comparative analysis.
The scaffolds of C. difficile 5.3 were reordered to match
the order in the finished genome of the closely related
strain C. difficile 630 using the Mauve Contig Mover
[11]. After reordering we find the genomes are free from
large-scale rearrangement. Rearrangement breakpoints
for some small translocated regions occur at sites anno-
tated with phage-related gene functions, suggesting that
bacteriophage may have lysogenized at different loca-
tions in each strain. The genome of C. difficile 5.3 was
aligned to those of C. difficile BI1, C. difficile 2007855,
and C. difficile 630 to characterize the extent of gene
content sharing and genomic rearrangement. A visualiza-
tion of the genome comparison produced by the Mauve
software is shown in Figure 2. From this figure we can
see that the majority of the genome is conserved among
all four isolates, although some strain-specific regions
exist.
Comparison of the gene content between C. difficile 5.3
and the finished C. difficile 630 reference genome identi-
fied 105 annotated gene functions predicted to be present
only in C. difficile 5.3. In particular, genes related to metal
resistance, bacitracin resistance, colicin resistance, drug
efflux, and several phage-related genes are present only
in C. difficile 5.3. These genes may contribute to the
pathogenic phenotype of C. difficile 5.3. A full list of these
genes has been provided in Additional file 1.
Future directions
Improved efficiency of the clinical genomics pipeline
will enable fine-scale epidemiological monitoring of
Clostridium difficile outbreaks.
Availability of supporting data
The draft genome assembly has been submitted to NCBI
and assigned accession PRJNA232267. Genome annota-
tions are available from the RASTweb server under acces-
sion 6666666.54620 when logged in with username guest,
password guest. The Illumina sequence reads have been
deposited to the Short Read Archive and under accession
SRX396630.
Additional file
Additional file 1: Listing of gene functions present in Clostridium
difficile 5.3 that are not found in the reference strain Clostridium
difficile 630.
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